ALDH2 and acute myeloid leukemia: However, this does not necessarily marginalize disulfiram use for AML, as the RNA expression of ALDH2 also has a significant association with unfavorable patient risk, when expression data from over 1000 patients of six leading AML studies were analyzed [21]; thus, both enzymes can be studied as potential targets for AML treatment.